Tags

Type your tag names separated by a space and hit enter

Pharmacokinetics, efficacy, and safety of analgesia with a focus on tramadol HCl.
Am J Med. 1996 Jul 31; 101(1A):47S-53S.AJ

Abstract

Chronic pain remains a problem because it is often misdiagnosed and undertreated. Adverse effects and safety concerns associated with many analgesics have limited the use of these agents and contributed to the undertreatment of pain. With regard to the pharmacologic agents most commonly used to manage pain, centrally acting analgesics (e.g., morphine, codeine) are associated with respiratory depression, tolerance, and dependence, and most nonsteroidal anti-inflammatory drugs (NSAIDs) produce adverse gastrointestinal effects. New to the United States, tramadol HCl, which has been prescribed for almost 2 decades in Europe, is a single-entity, centrally acting analgesic that is effective for the management of moderate to moderately severe pain. Although the mechanism of action of this analgesic is not completely understood, animal models suggest that at least two complementary modes of action appear applicable: (1) binding of parent compound and mono-O-desmethyltramadol (M1 metabolite) to the mu-opioid receptor and (2) weak inhibition of norepinephrine and serotonin reuptake. Clinical experience suggests that tramadol appears to have a low potential for abuse or addiction. Results from clinical trials conducted in the United States as well as European postmarketing surveillance studies indicate that tramadol is an effective analgesic that may have a particularly important role in the management of chronic painful conditions.

Authors+Show Affiliations

Ortho-McNeil Pharmaceutical, Raritan, New Jersey 08869, USA.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

8764760

Citation

Gibson, T P.. "Pharmacokinetics, Efficacy, and Safety of Analgesia With a Focus On Tramadol HCl." The American Journal of Medicine, vol. 101, no. 1A, 1996, 47S-53S.
Gibson TP. Pharmacokinetics, efficacy, and safety of analgesia with a focus on tramadol HCl. Am J Med. 1996;101(1A):47S-53S.
Gibson, T. P. (1996). Pharmacokinetics, efficacy, and safety of analgesia with a focus on tramadol HCl. The American Journal of Medicine, 101(1A), 47S-53S.
Gibson TP. Pharmacokinetics, Efficacy, and Safety of Analgesia With a Focus On Tramadol HCl. Am J Med. 1996 Jul 31;101(1A):47S-53S. PubMed PMID: 8764760.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Pharmacokinetics, efficacy, and safety of analgesia with a focus on tramadol HCl. A1 - Gibson,T P, PY - 1996/7/31/pubmed PY - 1996/7/31/medline PY - 1996/7/31/entrez SP - 47S EP - 53S JF - The American journal of medicine JO - Am. J. Med. VL - 101 IS - 1A N2 - Chronic pain remains a problem because it is often misdiagnosed and undertreated. Adverse effects and safety concerns associated with many analgesics have limited the use of these agents and contributed to the undertreatment of pain. With regard to the pharmacologic agents most commonly used to manage pain, centrally acting analgesics (e.g., morphine, codeine) are associated with respiratory depression, tolerance, and dependence, and most nonsteroidal anti-inflammatory drugs (NSAIDs) produce adverse gastrointestinal effects. New to the United States, tramadol HCl, which has been prescribed for almost 2 decades in Europe, is a single-entity, centrally acting analgesic that is effective for the management of moderate to moderately severe pain. Although the mechanism of action of this analgesic is not completely understood, animal models suggest that at least two complementary modes of action appear applicable: (1) binding of parent compound and mono-O-desmethyltramadol (M1 metabolite) to the mu-opioid receptor and (2) weak inhibition of norepinephrine and serotonin reuptake. Clinical experience suggests that tramadol appears to have a low potential for abuse or addiction. Results from clinical trials conducted in the United States as well as European postmarketing surveillance studies indicate that tramadol is an effective analgesic that may have a particularly important role in the management of chronic painful conditions. SN - 0002-9343 UR - https://www.unboundmedicine.com/medline/citation/8764760/Pharmacokinetics_efficacy_and_safety_of_analgesia_with_a_focus_on_tramadol_HCl_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0002-9343(96)00138-6 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.